Literature DB >> 7717468

Endoscopic laser management of supraglottic cancer.

S M Zeitels1, R K Davis.   

Abstract

Current concepts of endoscopic management of supraglottic cancer are an extension of precepts fostered by Jackson. The current approach has been facilitated by a half century of technological developments: the surgical microscope, the CO2 laser, improved laryngoscopes, and general endotracheal anesthesia. Selected small-volume cancers can be curatively resected, whereas excisional biopsy can be performed on larger neoplasms. With this cost effective minimally-invasive surgical approach, there is less disturbance of normal tissue, thereby minimizing morbidity rate and hospitalization. If the transoral excision is inadequate, radiotherapy can not be depended on to eradicate known residual disease. Endoscopic resection of supraglottic cancer should not alter the surgeon's standard management of the neck.

Entities:  

Mesh:

Year:  1995        PMID: 7717468     DOI: 10.1016/0196-0709(95)90002-0

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  3 in total

1.  Endoscopic supraglottic laryngectomy: a proposal for a classification by the working committee on nomenclature, European Laryngological Society.

Authors:  Marc Remacle; Anastasios Hantzakos; Hans Eckel; Anne-Sophie Evrard; Patrick J Bradley; Dominique Chevalier; Vojko Djukic; Marco de Vincentiis; Gerhard Friedrich; Jan Olofsson; Giorgio Peretti; Miquel Quer; Jochen Werner
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-01-08       Impact factor: 2.503

Review 2.  A novel distending laryngoscope: implications in transoral surgery.

Authors:  Michael L Hinni; Alpen B Patel; Thomas H Nagel; Brittany E Howard
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-31       Impact factor: 2.503

3.  Prognostic significance of surgical margins in transoral CO2 laser microsurgery for T1-T4 pharyngo-laryngeal cancers.

Authors:  Jose L Blanch; I Vilaseca; M Bernal-Sprekelsen; J J Grau; M Moragas; J Traserra-Coderch; M Caballero; F Sabater; J M Guilemany; L Alos
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-05-04       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.